Clinical Trial Update: Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK) [Phase 4]

View source ↗

Summary

A Phase 4 efficacy trial evaluating a left ventricular assist device for treating cardiogenic shock, including patients with myocardial infarction, has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• Left Ventricular Assist Device (Left Ventricular Assist Device)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Shock, Cardiogenic, Myocardial Infarction | Phase 4 | Status: COMPLETED